Association of Atrial Fibrillation and Oral Anticoagulant Use With Perioperative Outcomes After Major Noncardiac Surgery.

about

Association of Atrial Fibrillation and Oral Anticoagulant Use With Perioperative Outcomes After Major Noncardiac Surgery.

Item

http://www.wikidata.org/entity/Q47221597

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Association of Atrial Fibrilla ...... fter Major Noncardiac Surgery.

@en

Association of Atrial Fibrilla ...... fter Major Noncardiac Surgery.

@nl

type

Item

label

Association of Atrial Fibrilla ...... fter Major Noncardiac Surgery.

@en

Association of Atrial Fibrilla ...... fter Major Noncardiac Surgery.

@nl

prefLabel

Association of Atrial Fibrilla ...... fter Major Noncardiac Surgery.

@en

Association of Atrial Fibrilla ...... fter Major Noncardiac Surgery.

@nl

P1476

Association of Atrial Fibrilla ...... After Major Noncardiac Surgery

@en

P2093

Andrew C T Ha

http://www.w3.org/2001/XMLSchema#string

Clare L Atzema

http://www.w3.org/2001/XMLSchema#string

Husam M Abdel-Qadir

http://www.w3.org/2001/XMLSchema#string

Jiming Fang

http://www.w3.org/2001/XMLSchema#string

Peter C Austin

http://www.w3.org/2001/XMLSchema#string

Yin Ge

http://www.w3.org/2001/XMLSchema#string

P2860

Idarucizumab for Dabigatran Reversal

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.

National trends in oral anticoagulant use in the United States, 2007 to 2011

Rates of hemorrhage during warfarin therapy for atrial fibrillation.

Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort stu

Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis.

P31

scholarly article

P356

10.1161/JAHA.117.006022

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Duminda Wijeysundera

Dong-Hun Lee

P577

2017-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29233826

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

5778996

http://www.w3.org/2001/XMLSchema#string